Pegylated (40kDa) interferon alfa-2a (PEGASYS®) in combination with ribavirin: Efficacy and safety results from a phase III, randomized, actively-controlled, multicenter study

Authors:
  • MFMichael W. Fried
    Michael W. Fried
  • MSMitchell L. Shiffman
    Mitchell L. Shiffman
  • RRRejender K. Reddy
    Rejender K. Reddy
  • CSColeman Smith
    Coleman Smith
  • GMGeorge Marino
    George Marino
  • FGFemando Goncales
    Femando Goncales
  • DHDieter Haeussinger
    Dieter Haeussinger
  • MDMoises Diago
    Moises Diago
  • GCGiampietro Carosl
    Giampietro Carosl
  • JZJean-Pierre Zarski
    Jean-Pierre Zarski
  • JHJoseph Hoffman
    Joseph Hoffman
  • JYJian Yu
    Jian Yu

Abstract
No abstract available